Yan YY - Search Results

1

Microfluidics applications for high-throughput single cell sequencing.

Zhou WM, Yan YY, Guo QR, Ji H, Wang H, Xu TT, Makabel B, Pilarsky C, He G, Yu XY, Zhang JY. Zhou WM, et al. Among authors: yan yy. J Nanobiotechnology. 2021 Oct 11;19(1):312. doi: 10.1186/s12951-021-01045-6. J Nanobiotechnology. 2021. PMID: 34635104 Free PMC article. Review.

2

Parthenolide suppresses non-small cell lung cancer GLC-82 cells growth via B-Raf/MAPK/Erk pathway.

Lin M, Bi H, Yan Y, Huang W, Zhang G, Zhang G, Tang S, Liu Y, Zhang L, Ma J, Zhang J. Lin M, et al. Oncotarget. 2017 Apr 4;8(14):23436-23447. doi: 10.18632/oncotarget.15584. Oncotarget. 2017. PMID: 28423582 Free PMC article.

3

Anti-Cancer Effects of Pristimerin and the Mechanisms: A Critical Review.

Li JJ, Yan YY, Sun HM, Liu Y, Su CY, Chen HB, Zhang JY. Li JJ, et al. Among authors: yan yy. Front Pharmacol. 2019 Jul 12;10:746. doi: 10.3389/fphar.2019.00746. eCollection 2019. Front Pharmacol. 2019. PMID: 31354475 Free PMC article. Review.

4

Costunolide induces apoptosis and inhibits migration and invasion in H1299 lung cancer cells.

Wei M, Li J, Qiu J, Yan Y, Wang H, Wu Z, Liu Y, Shen X, Su C, Guo Q, Pan Y, Zhang P, Zhang J. Wei M, et al. Oncol Rep. 2020 Jun;43(6):1986-1994. doi: 10.3892/or.2020.7566. Epub 2020 Mar 26. Oncol Rep. 2020. PMID: 32236584 Free PMC article.

5

Exosomes with low miR-34c-3p expression promote invasion and migration of non-small cell lung cancer by upregulating integrin α2β1.

Huang W, Yan Y, Liu Y, Lin M, Ma J, Zhang W, Dai J, Li J, Guo Q, Chen H, Makabel B, Liu H, Su C, Bi H, Zhang J. Huang W, et al. Signal Transduct Target Ther. 2020 Apr 22;5(1):39. doi: 10.1038/s41392-020-0133-y. Signal Transduct Target Ther. 2020. PMID: 32317629 Free PMC article.

6

The Role of Exosomal microRNA in Cancer Drug Resistance.

Guo QR, Wang H, Yan YD, Liu Y, Su CY, Chen HB, Yan YY, Adhikari R, Wu Q, Zhang JY. Guo QR, et al. Among authors: yan yd, yan yy. Front Oncol. 2020 Apr 7;10:472. doi: 10.3389/fonc.2020.00472. eCollection 2020. Front Oncol. 2020. PMID: 32318350 Free PMC article. Review.

7

PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake.

Zhang JY, Yan YY, Li JJ, Adhikari R, Fu LW. Zhang JY, et al. Among authors: yan yy. Front Pharmacol. 2020 May 15;11:722. doi: 10.3389/fphar.2020.00722. eCollection 2020. Front Pharmacol. 2020. PMID: 32528284 Free PMC article. Review.

8

Pristimerin induces apoptosis and inhibits proliferation, migration in H1299 Lung Cancer Cells.

Li J, Guo Q, Lei X, Zhang L, Su C, Liu Y, Zhou W, Chen H, Wang H, Wang F, Yan Y, Zhang J. Li J, et al. J Cancer. 2020 Sep 2;11(21):6348-6355. doi: 10.7150/jca.44431. eCollection 2020. J Cancer. 2020. PMID: 33033518 Free PMC article.

9

The Biological Functions and Clinical Applications of Integrins in Cancers.

Su CY, Li JQ, Zhang LL, Wang H, Wang FH, Tao YW, Wang YQ, Guo QR, Li JJ, Liu Y, Yan YY, Zhang JY. Su CY, et al. Among authors: yan yy. Front Pharmacol. 2020 Sep 11;11:579068. doi: 10.3389/fphar.2020.579068. eCollection 2020. Front Pharmacol. 2020. PMID: 33041823 Free PMC article. Review.

10

Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer.

Su C, Wang H, Liu Y, Guo Q, Zhang L, Li J, Zhou W, Yan Y, Zhou X, Zhang J. Su C, et al. Front Oncol. 2020 Sep 17;10:554313. doi: 10.3389/fonc.2020.554313. eCollection 2020. Front Oncol. 2020. PMID: 33072580 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

236 results

Search Page